Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1

Những quyển sách tương tự

• Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro
  Bằng: Heredia, Alonso, et al.
  Được phát hành: (2007)
• CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells
  Bằng: Latinovic, Olga, et al.
  Được phát hành: (2011)
• CCR5 Inhibitors and HIV-1 Infection
  Bằng: Latinovic, Olga S., et al.
  Được phát hành: (2019)
• Synergistic Inhibition of R5 HIV-1 by Maraviroc and CCR5 Antibody HGS004 in Primary Cells: Implications for Treatment and Prevention
  Bằng: LATINOVIC, OLGA, et al.
  Được phát hành: (2011)
• Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
  Bằng: Latinovic, Olga, et al.
  Được phát hành: (2009)